Category: Featured

Join the DSECT/DSEN Monthly Seminar Series!

DSECT/DSEN present monthly online seminars for faculty, staff, trainees, decision makers and other stakeholders engaged in drug safety and effectiveness.

This month’s presentation by Dr. Anick Berard will be Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy.

Date: May 27, 2021
Time: 3:00-4:00 pm EST

RSVP:https://register.gotowebinar.com/register/1457674650757216523

Medications already available to treat other conditions are presently being studied in clinical trials as potential treatments for COVID-19. Given that pregnant women are excluded from these trials, we aimed to investigate their safety when used during pregnancy within a unique population source.

Using the population-based Quebec Pregnancy Cohort, we identified women who delivered a singleton liveborn (1998-2015). Taking potential confounders into account including indications for use, the risk of prematurity, low birth weight (LBW), small for gestational age (SGA), and major congenital malformation (MCM) associated with COVID-19 repurposed drug use during pregnancy were quantified using generalized estimation equations.

The Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program “bridges biosciences, clinical therapeutics, population health, epidemiology, biostatistics, and health services and policy research to better understand choosing, using and losing medications within the context of medication safety and effectiveness.”

For more information, please visit their website: http://www.safeandeffectiverx.com/.

CADTH is pleased to announce that the 2020 Virtual CADTH Symposium will be held online on November 9 and 10. Additional content will be available on-demand, including an e-poster gallery. Additional workshops will be held throughout the fall, winter, and spring.

All content will be presented free of charge.

The CADTH Symposium is widely considered a “must attend” event for anyone with an interest in the assessment, uptake, and management of drugs and medical devices in Canada. We anticipate that online attendance for this year’s virtual event will exceed 1,500 delegates from across Canada and beyond. Attendees will include health researchers; health economists; senior leaders from government, regional health authorities, hospitals, and other facilities; clinicians and patients; students; and industry representatives. As one of the major health technology assessment conferences in the world, the CADTH Symposium offers a unique opportunity for delegates to learn from local, national, and international experts, and to share their own expertise and knowledge.

Join the DSECT/DSEN Monthly Seminar Series!

DSECT/DSEN present monthly online seminars for faculty, staff, trainees, decision makers and other stakeholders engaged in drug safety and effectiveness.

This month’s presentation by Dr. Andrea Tricco, Dr. Brian Hutton and Ms. Shannon Kelly will be DSEN MAGIC Rapid Reviews and COVID-19.

Date: October 22, 2020
Time: 3:00-4:00 pm EST

RSVP: https://attendee.gotowebinar.com/register/1884742558523811856

COVID-19 has driven the need for timely evidence to inform decision-making. In this webinar, we will discuss the importance of rapid reviews during COVID-19 and present case examples of how the MAGIC team responded to queries from DSEN policy-makers through rapid reviews. We will also discuss methodological challenges associated with the conduct of rapid reviews on COVID-19.

The Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program “bridges biosciences, clinical therapeutics, population health, epidemiology, biostatistics, and health services and policy research to better understand choosing, using and losing medications within the context of medication safety and effectiveness.”

For more information, please visit their website: http://www.safeandeffectiverx.com/.

This training program bridges clinical therapeutics, active surveillance, administrative datasets, research methods, health services and policy, pharmaceutical policy, meta-analysis, and knowledge translation to better understand choosing, using, and losing medications within the context of drug safety and effectiveness.

The program offers opportunities for trainees across a broad spectrum of research areas to learn together and from each other as a key impetus for filling the critical void of skilled, knowledgeable researchers in the area of therapeutics.

For more information, visit DSECT’S website .

Dr. Anick Berard will present The Canadian Mother-Child Cohort Initiative as part of the DSECT/DESN Monthly Seminar Series on Thursday, May 23, 2019 between 3:00 pm and 4:00 pm EST.

Click to register.